555 related articles for article (PubMed ID: 9682495)
41. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
42. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
[TBL] [Abstract][Full Text] [Related]
43. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
44. Acute upper gastrointestinal bleeding in Jerusalem 1988-91: causes, characteristics and relation to nonsteroidal anti-inflammatory drugs.
Zimmerman J; Arnon R; Ligumski M; Beeri R; Keret D; Lysy J; Fich A; Tsvang E; Siguencia J; Gonzalez J
Isr J Med Sci; 1993 May; 29(5):292-7. PubMed ID: 8314690
[TBL] [Abstract][Full Text] [Related]
45. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
46. [Risk factors for peptic ulcer bleeding].
Søberg T; Hofstad B; Sandvik L; Johansen M; Lygren I
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1135-9. PubMed ID: 20531499
[TBL] [Abstract][Full Text] [Related]
47. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study.
Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T
Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264
[TBL] [Abstract][Full Text] [Related]
48. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
[TBL] [Abstract][Full Text] [Related]
49. [Risk factors in the development of bleeding peptic ulcer].
Stevanović D; Ivanisević V
Med Pregl; 1999; 52(9-10):379-84. PubMed ID: 10624388
[TBL] [Abstract][Full Text] [Related]
50. Drug-induced gastropathy in elderly Taiwanese.
Wu KL; Liou SH; Lay CS
Hepatogastroenterology; 2000; 47(32):596-600. PubMed ID: 10791246
[TBL] [Abstract][Full Text] [Related]
51. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.
Hansen JM; Hallas J; Lauritsen JM; Bytzer P
Scand J Gastroenterol; 1996 Feb; 31(2):126-30. PubMed ID: 8658033
[TBL] [Abstract][Full Text] [Related]
52. [Use of acetylsalicylic acid and other antiphlogistics in hematemesis/melena].
Breckan RK; Aabakken L
Tidsskr Nor Laegeforen; 1994 Jan; 114(3):313-6. PubMed ID: 8191427
[TBL] [Abstract][Full Text] [Related]
53. [The characteristics of peptic ulcer in subjects with concomitant ischemic heart disease].
Loginov AS; Zvenigorodskaia LA; Potapova VB; Arbuzova VG; Korzhikov VV; Nilova TV
Ter Arkh; 1998; 70(2):9-13. PubMed ID: 9551561
[TBL] [Abstract][Full Text] [Related]
54. [Upper gastrointestinal hemorrhage caused by anti-inflammatory agents].
Duhamel C; Czernichow P; Dechelotte P; Ducrotte P; Lerebours E; Colin R
Gastroenterol Clin Biol; 1989 Mar; 13(3):239-44. PubMed ID: 2786480
[TBL] [Abstract][Full Text] [Related]
55. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
56. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
57. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
58. [The duodenum and non-steroidal anti-inflammatory agents].
Pippa G; Apuzzo M; Bazuro ME; Tammaro G
Recenti Prog Med; 1990 Jun; 81(6):453-6. PubMed ID: 2251456
[TBL] [Abstract][Full Text] [Related]
59. [Clinical characteristics of non-steroidal anti-inflammatory drugs associated gastroduodenal ulcer bleeding].
Zhang L; Lu YM; Ding SG; Liao ZL
Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):258-60. PubMed ID: 12887811
[TBL] [Abstract][Full Text] [Related]
60. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
